Top Markets
#1 Zora Zora +43.81%
#2 AI XOVIA AI XOVIA +37.42%
#3 0G 0G +21.07%
#4 Full Moon Full Moon +19.35%
#5 Axelar Axelar +17.04%
#6 Notcoin Notcoin +13.85%
#7 ZKsync ZKsync +12.68%
#8 Wrapped NXM Wrapped NXM +12.14%
#9 rsERG rsERG +12.06%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +10.43%
Coin of the day
Zora Zora
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
Pozycja w akcjach #12325
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established... Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Cena akcji
$11.03
Ostatnia synchronizacja: 2026-08-28
Kapitalizacja rynkowa
$597.15M
Zmiana (1 dzień)
-4.25%
Zmiana (1 rok)
-
Kraj
US
Handel Eikon Therapeutics, Inc. Common Stock (EIKN)

Kategoria

Healthcare
Zyski dla Eikon Therapeutics, Inc. Common Stock (EIKN)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Eikon Therapeutics, Inc. Common Stock, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Eikon Therapeutics, Inc. Common Stock od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH